Seeing Is Believing
MLTX is currently covered by 11 analysts with an average price target of $28.85. This is a potential upside of $18.27 (172.68%) from yesterday's end of day stock price of $10.58.
MoonLake Immunotherapeutics's activity chart (see below) currently has 124 price targets and 139 ratings on display. The stock rating distribution of MLTX is 72.41% BUY, 24.14% HOLD and 3.45% SELL.
Analysts average stock forecasts to be materialized ratio is 29.18% with an average time for these price targets to be met of 92.79 days.
Highest price target for MLTX is $70, Lowest price target is $5, average price target is $28.85.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT. First documented stock forecast 20-Jul-2022.
Currently out of the existing stock ratings of MLTX, 21 are a BUY (72.41%), 7 are a HOLD (24.14%), 1 are a SELL (3.45%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Nov-2025
$50
$38.62 (339.37%)
$50
Buy Since 17-Jul-2023
$29
$17.62 (154.83%)
3 months 8 days ago
(30-Jun-2026)
1/3 (33.33%)
$9.87 (51.59%)
173
Buy Since 09-Feb-2026
$30
$10.1 (50.75%)
$30
3 months 29 days ago
(09-Jun-2026)
2/10 (20%)
$12.2 (68.54%)
61
Buy Since 31-Aug-2023
$30
$10.1 (50.75%)
$25
4 months 26 days ago
(12-May-2026)
1/16 (6.25%)
$11.81 (64.93%)
265
Sell Since 23-Mar-2026
$24
$4.1 (20.60%)
$61
6 months 15 days ago
(23-Mar-2026)
1/2 (50%)
$7.13 (42.26%)
112
What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MLTX (MoonLake Immunotherapeutics)?
Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?